Brain Disease Device And Software Global Market Report 2026
상품코드:1942481
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
뇌질환용 의료기기 및 소프트웨어 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 155억 9,000만 달러에서 2026년에는 172억 달러로 성장하며, CAGR은 10.3%에 달할 전망입니다. 지난 수년간의 성장 요인으로는 뇌질환 진단 툴공급 부족, 신경질환 유병률 증가, 병원 및 클리닉 인프라 확충, 원격의료 솔루션의 초기 도입, 기존 뇌영상 진단 기술에 대한 의존도 등을 들 수 있습니다.
뇌질환용 디바이스 및 소프트웨어 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 252억 1,000만 달러에 달하며, CAGR은 10.0%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 웨어러블 및 AI 기반 뇌질환 디바이스 발전, 신경 재활 기술에 대한 투자 증가, 홈케어 및 원격 모니터링 솔루션 확대, 뇌 데이터 관리 소프트웨어 수요 증가, 신경정보학 및 인지 평가 기술 연구 발전 등이 꼽힙니다. 있습니다. 예측 기간 중 주요 동향으로는 신경 자극기 및 뇌 모니터링 장치 도입 확대, 원격의료와 원격 환자 모니터링의 통합, 인지 평가 및 신경 피드백 소프트웨어의 성장, 개인 맞춤형 뇌 질환 치료에 대한 관심 증가, 신경 영상 진단 및 데이터 분석 솔루션의 확대 등을 들 수 있습니다.
신경질환의 유병률 증가는 뇌질환용 기기 및 소프트웨어 시장의 성장을 촉진할 것으로 예측됩니다. 신경질환은 뇌, 척수, 신경에 영향을 미쳐 인지기능, 운동기능, 감각기능의 장애를 유발합니다. 그 발생률 증가는 세계 인구의 고령화와 관련이 있으며, 노화는 신경세포 기능을 저하시키고, 뇌의 가소성을 감소시키며, 산화 스트레스를 증가시켜 질병의 발병과 진행에 기여합니다. 뇌 질환을 위한 장치와 소프트웨어는 조기 진단과 지속적인 모니터링을 가능하게 함으로써 이러한 질환을 관리할 수 있도록 돕습니다. 고급 AI와 데이터 분석은 적시에 개입할 수 있도록 지원하여 환자 치료와 치료 결과를 개선하는 데 기여합니다. 예를 들어 2024년 7월 영국 국민보건서비스(NHS)는 2024년 6월 30일 기준 치매 진단을 받은 환자 수가 487,432명에 이르렀다고 보고했습니다. 이는 2024년 5월 31일 기준 대비 3,155명이 증가한 수치입니다. 그 결과, 신경질환 유병률 증가는 뇌질환용 기기 및 소프트웨어 시장의 성장을 가속하고 있습니다.
뇌질환용 기기 및 소프트웨어 시장에서 사업을 운영하는 주요 기업은 알츠하이머병과 치매를 포함한 신경퇴행성 질환의 조기 발견, 모니터링, 관리를 개선하기 위해 인공지능(AI)을 활용한 뇌 영상 분석 등 첨단 기술 도입에 주력하고 있습니다. 인공지능 기반 뇌영상 분석은 MRI 및 기타 신경영상 데이터세트에 머신러닝 알고리즘을 활용하여 기존의 체적 영상 진단으로는 포착할 수 없는 뇌조직의 미세한 미세구조 변화를 감지하여 보다 빠르고 민감한 진단을 가능케 하는 첨단 소프트웨어 플랫폼을 말합니다. 가능하게 합니다. 예를 들어 2025년 1월 영국에 본사를 둔 의료 기술 기업 Oxford Brain Diagnostics는 미국 식품의약국(FDA)의 510(k) 승인을 획득한 후, 독자적인 대뇌피질 불규칙성 측정(CDM) 기술을 기반으로 구축된 클라우드 네이티브 소프트웨어 솔루션 'CDM 인사이트'를 출시했습니다. 이 솔루션은 표준 1.5T 및 3T MRI 스캔을 평가하여 회백질의 피질 두께와 미세구조의 교란에 대한 새로운 지표를 생성함으로써 신경 퇴행의 객관적이고 정량적인 마커를 제공합니다. 규제 당국의 승인을 받은 후, 회사는 미국과 영국의 의료 시스템 전반에 걸쳐 상업적 배포를 시작하여 임상의의 조기 진단, 질병 모니터링 및 치료법 계층화를 지원하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Brain disease devices and software refer to specialized medical tools and digital applications designed to diagnose, monitor, and manage neurological disorders and brain-related conditions. These solutions assist in detecting abnormalities, guiding therapies, and managing diseases, with the primary goal of improving patient outcomes through accurate assessment, personalized treatment, and continuous brain health monitoring.
The main categories of brain disease devices and software are brain disease devices and brain disease software. Brain disease devices are medical tools developed to diagnose, monitor, treat, or support rehabilitation for neurological disorders affecting brain function. They leverage technologies such as wearable devices, telemedicine platforms, artificial intelligence and machine learning, mobile health applications, and neuroimaging techniques. These devices are applied in conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and other neurological disorders, serving end users including hospitals and clinics, home care settings, rehabilitation centers, research and academic institutions, and diagnostic laboratories.
Tariffs are impacting the brain disease device and software market by increasing costs of imported high-tech equipment such as neuroimaging systems, wearable devices, and AI-enabled software platforms. Segments like neurostimulation devices and advanced brain imaging tools are most impacted, particularly in regions like North America and Asia-Pacific, where imports constitute a major share of supply. This has led to higher production costs and slowed adoption in some clinical and research settings. Positively, tariffs are encouraging local manufacturing, development of cost-effective alternatives, and innovation in domestic brain health solutions.
The brain disease device and software market research report is one of a series of new reports from The Business Research Company that provides brain disease device and software market statistics, including brain disease device and software industry global market size, regional shares, competitors with a brain disease device and software market share, detailed brain disease device and software market segments, market trends and opportunities, and any further data you may need to thrive in the brain disease device and software industry. This brain disease device and software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The brain disease device and software market size has grown rapidly in recent years. It will grow from $15.59 billion in 2025 to $17.2 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to limited availability of brain disease diagnostic tools, growing prevalence of neurological disorders, rising hospital and clinic infrastructure, early-stage adoption of telemedicine solutions, dependence on traditional brain imaging techniques.
The brain disease device and software market size is expected to see rapid growth in the next few years. It will grow to $25.21 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to advancements in wearable and ai-enabled brain disease devices, increased investment in neurorehabilitation technologies, expansion of home care and remote monitoring solutions, rising demand for brain data management software, growing research in neuroinformatics and cognitive assessment technologies. Major trends in the forecast period include rising adoption of neurostimulation and brain monitoring devices, integration of telemedicine and remote patient monitoring, growth in cognitive assessment and neurofeedback software, increasing focus on personalized brain disorder treatment, expansion of neuroimaging and data analytics solutions.
The rising prevalence of neurological disorders is expected to drive growth in the brain disease device and software market. Neurological disorders affect the brain, spinal cord, and nerves, causing cognitive, motor, and sensory impairments. Their increasing occurrence is associated with the aging global population, as aging reduces neuronal function, decreases brain plasticity, and increases oxidative stress, contributing to disease onset and progression. Brain disease devices and software aid in managing these conditions by enabling early diagnosis and continuous monitoring. Advanced AI and data analytics support timely intervention, improving patient care and treatment outcomes. For example, in July 2024, the UK's National Health Service reported 487,432 patients diagnosed with dementia by June 30, 2024, an increase of 3,155 cases compared to May 31, 2024. Consequently, the growing prevalence of neurological disorders is fueling the brain disease device and software market.
Major companies operating in the brain disease device and software market are increasingly concentrating on the adoption of advanced technologies, such as artificial intelligence (AI)-enabled brain imaging analytics, to improve the early and precise detection, monitoring, and management of neurodegenerative disorders including Alzheimer's disease and dementia. Artificial intelligence-driven brain imaging analytics refers to sophisticated software platforms that utilize machine-learning algorithms on MRI and other neuroimaging datasets to detect subtle microstructural changes in brain tissue that may not be captured by conventional volumetric imaging, thereby facilitating earlier and more sensitive diagnosis. For example, in January 2025, Oxford Brain Diagnostics Ltd., a UK-based medtech company, obtained U.S. Food and Drug Administration (FDA) 510(k) clearance and subsequently launched CDM Insights, a cloud-native software solution built on its proprietary Cortical Disarray Measurement (CDM) technology. The solution evaluates standard 1.5 T and 3 T MRI scans to produce novel metrics of cortical thickness and microstructural disarray in grey matter, delivering objective and quantifiable markers of neurodegeneration. Following regulatory clearances, the company commenced commercial deployment across healthcare systems in the US and UK, assisting clinicians with early diagnosis, disease monitoring, and treatment stratification.
In January 2025, NVIDIA entered into a partnership with Synchron Inc. to advance implantable brain-computer interface (BCI) technology through the use of NVIDIA's Holoscan platform, enabling real-time neural processing and scalable brain-language models. Through this collaboration, NVIDIA Corporation seeks to integrate Synchron's brain-computer interface platforms to enhance AI-driven neural signal processing and real-time analytics, thereby accelerating innovation in next-generation BCI applications. Synchron Inc., a US-based healthcare technology company, specializes in the development of minimally invasive brain-computer interface devices that facilitate neural signal acquisition and interaction for clinical and research applications.
Major companies operating in the brain disease device and software market are Medtronic plc, Insightec Ltd., Cadwell Industries Inc., NeuroPace Inc., Synchron Inc., Compumedics Ltd., Neuronetics Inc., BrainsWay Ltd., The Magstim Company Ltd., Paradromics Inc., Linus Health Inc., MagVenture A/S, Neurophet Inc., Neuroelectrics Corporation, BrainScope Company Inc, Blackrock Neurotech LLC, Neurable Inc., NeuroSigma Inc., Cognixion Inc., Brightmind.AI
North America was the largest region in the brain disease device and software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain disease device and software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the brain disease device and software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The brain disease device and software market consists of revenues earned by entities by providing services such as brain mapping services, remote neurological consultation, neurocognitive assessment, neurofeedback therapy, and personalised rehabilitation planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The brain disease devices and software market also includes sales of brain-computer interface systems, intracranial pressure monitors, transcranial magnetic stimulation devices, virtual reality-based rehabilitation kits, and portable electroencephalography headsets. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Brain Disease Device And Software Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses brain disease device and software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for brain disease device and software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The brain disease device and software market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Brain Disease Device; Brain Disease Software
2) By Technology: Wearable Technology; Telemedicine Solutions; Artificial Intelligence And Machine Learning; Mobile Health Applications; Neuroimaging Technologies
3) By Application: Alzheimer's Disease; Parkinson's Disease; Epilepsy; Other Applications
4) By End-User: Hospitals And Clinics; Home Care Settings; Rehabilitation Centers; Research and Academic Institutions; Diagnostic Laboratories
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
4.1.3 Biotechnology, Genomics & Precision Medicine
4.1.4 Industry 4.0 & Intelligent Manufacturing
4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
4.2. Major Trends
4.2.1 Rising Adoption Of Neurostimulation And Brain Monitoring Devices
4.2.2 Integration Of Telemedicine And Remote Patient Monitoring
4.2.3 Growth In Cognitive Assessment And Neurofeedback Software
4.2.4 Increasing Focus On Personalized Brain Disorder Treatment
4.2.5 Expansion Of Neuroimaging And Data Analytics Solutions
5. Brain Disease Device And Software Market Analysis Of End Use Industries
5.1 Hospitals And Clinics
5.2 Home Care Settings
5.3 Rehabilitation Centers
5.4 Research And Academic Institutions
5.5 Diagnostic Laboratories
6. Brain Disease Device And Software Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Brain Disease Device And Software Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Brain Disease Device And Software PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Brain Disease Device And Software Market Size, Comparisons And Growth Rate Analysis
7.3. Global Brain Disease Device And Software Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Brain Disease Device And Software Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Brain Disease Device And Software Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Brain Disease Device And Software Market Segmentation
9.1. Global Brain Disease Device And Software Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Brain Disease Device, Brain Disease Software
9.2. Global Brain Disease Device And Software Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Wearable Technology, Telemedicine Solutions, Artificial Intelligence And Machine Learning, Mobile Health Applications, Neuroimaging Technologies
9.3. Global Brain Disease Device And Software Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Alzheimer's Disease, Parkinson's Disease, Epilepsy, Other Applications
9.4. Global Brain Disease Device And Software Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals And Clinics, Home Care Settings, Rehabilitation Centers, Research and Academic Institutions, Diagnostic Laboratories
9.5. Global Brain Disease Device And Software Market, Sub-Segmentation Of Brain Disease Device, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Brain Disease Device And Software Market, Sub-Segmentation Of Brain Disease Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. Brain Disease Device And Software Market Regional And Country Analysis
10.1. Global Brain Disease Device And Software Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Brain Disease Device And Software Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Brain Disease Device And Software Market
11.1. Asia-Pacific Brain Disease Device And Software Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Brain Disease Device And Software Market
12.1. China Brain Disease Device And Software Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Brain Disease Device And Software Market
13.1. India Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Brain Disease Device And Software Market
14.1. Japan Brain Disease Device And Software Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Brain Disease Device And Software Market
15.1. Australia Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Brain Disease Device And Software Market
16.1. Indonesia Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Brain Disease Device And Software Market
17.1. South Korea Brain Disease Device And Software Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Brain Disease Device And Software Market
18.1. Taiwan Brain Disease Device And Software Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Brain Disease Device And Software Market
19.1. South East Asia Brain Disease Device And Software Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Brain Disease Device And Software Market
20.1. Western Europe Brain Disease Device And Software Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Brain Disease Device And Software Market
21.1. UK Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Brain Disease Device And Software Market
22.1. Germany Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Brain Disease Device And Software Market
23.1. France Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Brain Disease Device And Software Market
24.1. Italy Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Brain Disease Device And Software Market
25.1. Spain Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Brain Disease Device And Software Market
26.1. Eastern Europe Brain Disease Device And Software Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Brain Disease Device And Software Market
27.1. Russia Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Brain Disease Device And Software Market
28.1. North America Brain Disease Device And Software Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Brain Disease Device And Software Market
29.1. USA Brain Disease Device And Software Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Brain Disease Device And Software Market
30.1. Canada Brain Disease Device And Software Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Brain Disease Device And Software Market
31.1. South America Brain Disease Device And Software Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Brain Disease Device And Software Market
32.1. Brazil Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Brain Disease Device And Software Market
33.1. Middle East Brain Disease Device And Software Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Brain Disease Device And Software Market
34.1. Africa Brain Disease Device And Software Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Brain Disease Device And Software Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Brain Disease Device And Software Market Regulatory and Investment Landscape
36. Brain Disease Device And Software Market Competitive Landscape And Company Profiles
36.1. Brain Disease Device And Software Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Brain Disease Device And Software Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Brain Disease Device And Software Market Company Profiles
36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Insightec Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Cadwell Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. NeuroPace Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Synchron Inc. Overview, Products and Services, Strategy and Financial Analysis
37. Brain Disease Device And Software Market Other Major And Innovative Companies
Compumedics Ltd., Neuronetics Inc., BrainsWay Ltd., The Magstim Company Ltd., Paradromics Inc., Linus Health Inc., MagVenture A/S, Neurophet Inc., Neuroelectrics Corporation, BrainScope Company Inc, Blackrock Neurotech LLC, Neurable Inc., NeuroSigma Inc., Cognixion Inc., Brightmind.AI
38. Global Brain Disease Device And Software Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Brain Disease Device And Software Market
40. Brain Disease Device And Software Market High Potential Countries, Segments and Strategies
40.1 Brain Disease Device And Software Market In 2030 - Countries Offering Most New Opportunities
40.2 Brain Disease Device And Software Market In 2030 - Segments Offering Most New Opportunities
40.3 Brain Disease Device And Software Market In 2030 - Growth Strategies
